Target Price | $148.67 |
Price | $68.33 |
Potential |
117.57%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Praxis Precision Medicines Inc 2025 .
The average Praxis Precision Medicines Inc target price is $148.67.
This is
117.57%
register free of charge
$270.00
295.14%
register free of charge
$51.00
25.36%
register free of charge
|
|
A rating was issued by 10 analysts: 9 Analysts recommend Praxis Precision Medicines Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Praxis Precision Medicines Inc stock has an average upside potential 2025 of
117.57%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 2.45 | 1.48 |
39.68% | ||
EBITDA Margin | -5,140.41% | -11,330.42% |
120.42% | ||
Net Margin | -13,548.34% | -10,076.98% |
25.62% |
10 Analysts have issued a sales forecast Praxis Precision Medicines Inc 2024 . The average Praxis Precision Medicines Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Praxis Precision Medicines Inc 2024 . The average Praxis Precision Medicines Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Praxis Precision Medicines Inc Analysts have issued a net profit forecast 2024. The average Praxis Precision Medicines Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -18.69 | -8.39 |
73.17% | 55.11% | |
P/E | negative | |
EV/Sales | 584.25 |
4 Analysts have issued a Praxis Precision Medicines Inc forecast for earnings per share. The average Praxis Precision Medicines Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Praxis Precision Medicines Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Praxis Precision Medicines Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.